The Oncology Institute, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $132.0M | $95.5M |
| Jun 2022 | — | $124.0M | $64.2M |
| Sep 2022 | $79.1M | $127.9M | $61.4M |
| Dec 2022 | $80.6M | $123.2M | $14.0M |
| Mar 2023 | $82.1M | $98.4M | $15.3M |
| Jun 2023 | $83.7M | $84.7M | $28.9M |
| Sep 2023 | $85.3M | $71.8M | $27.5M |
| Dec 2023 | $86.8M | $57.0M | $33.5M |
| Mar 2024 | $88.4M | $41.3M | $36.1M |
| Jun 2024 | $90.0M | $29.2M | $36.4M |
| Sep 2024 | $91.5M | $15.5M | $47.4M |
| Dec 2024 | $93.1M | $3.6M | $49.7M |
| Mar 2025 | $73.9M | $5.1M | $39.7M |
| Jun 2025 | $75.0M | $-9.0M | $30.3M |
| Sep 2025 | $76.2M | $-12.3M | $27.7M |
| Dec 2025 | $77.4M | $-15.7M | $33.6M |
| Mar 2026 | $78.6M | $-16.3M | $30.3M |
| Jun 2026 | $79.9M | $-24.9M | $41.1M |